Role of hydroxychloroquine in multidrug treatment of COVID-19
Rev Cardiovasc Med
.
2021 Sep 24;22(3):545-546.
doi: 10.31083/j.rcm2203063.
Authors
Peter A McCullough
1
,
Raphael B Stricker
2
,
Harvey A Risch
3
Affiliations
1
Truth for Health Foundation, Tucson, AZ, USA.
2
Union Square Medical Associates, San Francisco, CA, USA.
3
Yale School of Public Health, New Haven, CT 06510, USA.
PMID:
34565055
DOI:
10.31083/j.rcm2203063
No abstract available
Keywords:
Ambulatory treatment; COVID-19; Hydroxychloroquine; Mortality; SARS-CoV-2.
Publication types
Editorial
Comment
MeSH terms
COVID-19 Drug Treatment*
Coronavirus Infections*
Humans
Hydroxychloroquine / adverse effects
SARS-CoV-2
Substances
Hydroxychloroquine